1
Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome
Condition(s):Peripheral Nerve Injuries; PainLast Updated:July 21, 2015Withdrawn
Rufinamide as an Intervention: 16 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures
Condition(s):Refractory Partial SeizuresLast Updated:September 22, 2020Withdrawn
3
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
Condition(s):EpilepsyLast Updated:June 14, 2021Completed
4
An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303
Condition(s):Lennox Gastaut SyndromeLast Updated:May 6, 2023Available
5
Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects
Condition(s):SeizuresLast Updated:January 6, 2015Completed
6
Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
Condition(s):Refractory Partial Onset SeizuresLast Updated:November 22, 2019Terminated
7
A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
Condition(s):Lennox-Gastaut SyndromeLast Updated:March 11, 2019Completed
8
Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome
Condition(s):Lennox-Gastaut SyndromeLast Updated:February 21, 2023Completed
9
Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs
Condition(s):Lennox-Gastaut SyndromeLast Updated:August 6, 2019Completed
10
Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)
Condition(s):Generalized Anxiety DisorderLast Updated:February 27, 2019Completed